ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
fluffington
|
17K |
6.7M |
8 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
fluffington
|
9.8K |
2.9M |
2 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
9.8K
|
2.9M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
fluffington
|
9.8K |
2.9M |
5 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
9.8K
|
2.9M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
fluffington
|
623 |
271K |
6 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
623
|
271K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
fluffington
|
671 |
234K |
0 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
671
|
234K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
fluffington
|
1.0K |
405K |
5 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
1.0K
|
405K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
fluffington
|
244 |
88K |
0 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
244
|
88K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
fluffington
|
1.0K |
405K |
14 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
1.0K
|
405K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
fluffington
|
558 |
185K |
7 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
558
|
185K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
fluffington
|
558 |
185K |
3 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
558
|
185K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
fluffington
|
671 |
234K |
4 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
671
|
234K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
fluffington
|
671 |
234K |
4 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
671
|
234K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
fluffington
|
558 |
185K |
5 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
558
|
185K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
fluffington
|
558 |
185K |
5 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
558
|
185K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
fluffington
|
204 |
77K |
7 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
204
|
77K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
fluffington
|
204 |
77K |
34 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
204
|
77K
|
34
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
fluffington
|
623 |
271K |
4 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
623
|
271K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
fluffington
|
623 |
271K |
8 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
623
|
271K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
fluffington
|
623 |
271K |
5 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
623
|
271K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
fluffington
|
273 |
123K |
9 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
273
|
123K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
fluffington
|
9.8K |
2.9M |
1 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
9.8K
|
2.9M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
fluffington
|
1.0K |
405K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
1.0K
|
405K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
fluffington
|
549 |
178K |
1 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
549
|
178K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
$2 PARTY
|
|
fluffington
|
9.4K |
1.6M |
2 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
9.4K
|
1.6M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Financial Results Presentation
|
|
fluffington
|
78 |
25K |
5 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
78
|
25K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Half Yearly Report and Accounts
|
|
fluffington
|
147 |
34K |
5 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
147
|
34K
|
5
|
|
ASX - By Stock
|
ZIP |
Re:
$2 PARTY
|
|
fluffington
|
9.4K |
1.6M |
12 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
9.4K
|
1.6M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
fluffington
|
102 |
38K |
7 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
102
|
38K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
fluffington
|
716 |
202K |
2 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
716
|
202K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Entitlement Offer and Placement Investor Presentation
|
|
fluffington
|
48 |
15K |
9 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
48
|
15K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
fluffington
|
716 |
202K |
1 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
716
|
202K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
fluffington
|
716 |
202K |
11 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
716
|
202K
|
11
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation to Annual General Meeting
|
|
fluffington
|
62 |
19K |
10 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
62
|
19K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
fluffington
|
3.4K |
1.2M |
6 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
fluffington
|
38 |
16K |
16 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
38
|
16K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
fluffington
|
38 |
16K |
7 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
38
|
16K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
2023 Next Steps
|
|
fluffington
|
165 |
66K |
12 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
165
|
66K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
fluffington
|
1.3K |
553K |
28 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
553K
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
fluffington
|
17K |
6.7M |
19 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
17K
|
6.7M
|
19
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESO watch and banter
|
|
fluffington
|
400 |
151K |
3 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
400
|
151K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESO watch and banter
|
|
fluffington
|
400 |
151K |
11 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
400
|
151K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
ODAC August 2020 event materials
|
|
fluffington
|
85 |
25K |
10 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
85
|
25K
|
10
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESO watch and banter
|
|
fluffington
|
400 |
151K |
14 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
400
|
151K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
fluffington
|
207 |
61K |
4 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
207
|
61K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
fluffington
|
207 |
61K |
8 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
207
|
61K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection
|
|
fluffington
|
275 |
111K |
13 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
275
|
111K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
fluffington
|
1.0K |
391K |
9 |
09/03/23 |
09/03/23 |
ASX - By Stock
|
1.0K
|
391K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
fluffington
|
74 |
28K |
3 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
74
|
28K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
fluffington
|
74 |
28K |
6 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
74
|
28K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel Clinical and Potency Studies Presented at Tandem
|
|
fluffington
|
217 |
70K |
8 |
07/03/23 |
07/03/23 |
ASX - By Stock
|
217
|
70K
|
8
|
|